Search Page

1

Cite

Share

Precision Medicine in Non-Communicable Diseases.

Novelli G, Biancolella M, Latini A, Spallone A, Borgiani P, Papaluca M. Novelli G, et al. Among authors: papaluca m. High Throughput. 2020 Feb 7;9(1):3. doi: 10.3390/ht9010003. High Throughput. 2020. PMID: 32046063 Free PMC article.

Cite

Share

2

Cite

Share

European Medicines Agency initiatives and perspectives on pharmacogenomics.

Ehmann F, Caneva L, Papaluca M. Ehmann F, et al. Among authors: papaluca m. Br J Clin Pharmacol. 2014 Apr;77(4):612-7. doi: 10.1111/bcp.12319. Br J Clin Pharmacol. 2014. PMID: 24433361 Free PMC article. Review.

Cite

Share

3

Cite

Share

Nanomedicines in the EU-Regulatory Overview.

Pita R, Ehmann F, Papaluca M. Pita R, et al. Among authors: papaluca m. AAPS J. 2016 Nov;18(6):1576-1582. doi: 10.1208/s12248-016-9967-1. Epub 2016 Aug 15. AAPS J. 2016. PMID: 27527889

Cite

Share

4

Cite

Share

White spots in pharmaceutical pipelines-EMA identifies potential areas of unmet medical needs.

Papaluca M, Greco M, Tognana E, Ehmann F, Saint-Raymond A. Papaluca M, et al. Expert Rev Clin Pharmacol. 2015 May;8(3):353-60. doi: 10.1586/17512433.2015.1028918. Epub 2015 Mar 23. Expert Rev Clin Pharmacol. 2015. PMID: 25797498 Review.

Cite

Share

5

Cite

Share

Pharmacogenetics in the evaluation of new drugs: a multiregional regulatory perspective.

Maliepaard M, Nofziger C, Papaluca M, Zineh I, Uyama Y, Prasad K, Grimstein C, Pacanowski M, Ehmann F, Dossena S, Paulmichl M. Maliepaard M, et al. Among authors: papaluca m. Nat Rev Drug Discov. 2013 Feb;12(2):103-15. doi: 10.1038/nrd3931. Nat Rev Drug Discov. 2013. PMID: 23370249 Review.

Cite

Share

6

Cite

Share

Expanded access: growing importance to public health.

Borysowski J, Saxena A, Bateman-House A, Papaluca M, Różyńska J, Wnukiewicz-Kozłowska A, Górski A. Borysowski J, et al. Among authors: papaluca m. J Epidemiol Community Health. 2018 Jul;72(7):557-558. doi: 10.1136/jech-2017-210409. Epub 2018 Apr 7. J Epidemiol Community Health. 2018. PMID: 29627785 No abstract available.

Cite

Share

7

Cite

Share

Changes and determination of dosing recommendations for medicinal products recently authorised in the European Union.

Ehmann F, Papaluca M, Di Giuseppe F, Pani L, Eskova A, Manolis E, Herold R. Ehmann F, et al. Among authors: papaluca m. Expert Opin Pharmacother. 2015 Apr;16(6):903-11. doi: 10.1517/14656566.2015.1025050. Epub 2015 Mar 14. Expert Opin Pharmacother. 2015. PMID: 25773468 Review.

Cite

Share

8

Cite

Share

A European regulatory perspective on cystic fibrosis: current treatments, trends in drug development and translational challenges for CFTR modulators.

Ponzano S, Nigrelli G, Fregonese L, Eichler I, Bertozzi F, Bandiera T, Galietta LJV, Papaluca M. Ponzano S, et al. Among authors: papaluca m. Eur Respir Rev. 2018 Apr 13;27(148):170124. doi: 10.1183/16000617.0124-2017. Print 2018 Jun 30. Eur Respir Rev. 2018. PMID: 29653946 Free article. Review.

Cite

Share

9

Cite

Share

Precision medicine in the age of big data: The present and future role of large-scale unbiased sequencing in drug discovery and development.

Vicini P, Fields O, Lai E, Litwack ED, Martin AM, Morgan TM, Pacanowski MA, Papaluca M, Perez OD, Ringel MS, Robson M, Sakul H, Vockley J, Zaks T, Dolsten M, Søgaard M. Vicini P, et al. Among authors: papaluca m. Clin Pharmacol Ther. 2016 Feb;99(2):198-207. doi: 10.1002/cpt.293. Epub 2015 Dec 19. Clin Pharmacol Ther. 2016. PMID: 26536838 Review.

Cite

Share

10

Cite

Share

Assessing the long-term safety and efficacy of COVID-19 vaccines.

Majeed A, Papaluca M, Molokhia M. Majeed A, et al. Among authors: papaluca m. J R Soc Med. 2021 Jul;114(7):337-340. doi: 10.1177/01410768211013437. Epub 2021 May 4. J R Soc Med. 2021. PMID: 33945346 Free article. No abstract available.

Cite

Share